Hyperbilirubinemia：治療薬のグローバル治験動向（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Hyperbilirubinemia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Hyperbilirubinemia to Metabolic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hyperbilirubinemia to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Hyperbilirubinemia Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
InfaCare Pharmaceutical Corporation 29
Clinical Trial Overview of InfaCare Pharmaceutical Corporation 29
Mednax, Inc. 30
Clinical Trial Overview of Mednax, Inc. 30
Clinical Trial Overview of Top Institutes / Government 31
Mashhad University of Medical Sciences 31
Clinical Trial Overview of Mashhad University of Medical Sciences 31
University of Rochester 32
Clinical Trial Overview of University of Rochester 32
Eunice Kennedy Shriver National Institute of Child Health and Human Development 33
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 33
Kermanshah University of Medical Sciences 34
Clinical Trial Overview of Kermanshah University of Medical Sciences 34
University Medical Center Groningen 35
Clinical Trial Overview of University Medical Center Groningen 35
University of California, San Francisco 36
Clinical Trial Overview of University of California, San Francisco 36
Radboud University 37
Clinical Trial Overview of Radboud University 37
Cirujanos la Serena 38
Clinical Trial Overview of Cirujanos la Serena 38
Nanjing Medical University 39
Clinical Trial Overview of Nanjing Medical University 39
Children’s Oncology Group 40
Clinical Trial Overview of Children’s Oncology Group 40
Five Key Clinical Profiles 41
Appendix 63
Abbreviations 63
Definitions 63
Research Methodology 64
Secondary Research 64
About GlobalData 65
Contact Us 65
Disclaimer 65
Source 65